Protalix BioTherapeutics, Inc. (PLX)
NYSEAMERICAN: PLX · Real-Time Price · USD
2.620
-0.160 (-5.76%)
Mar 6, 2026, 4:00 PM EST - Market closed
Protalix BioTherapeutics Employees
Protalix BioTherapeutics had 213 employees as of December 31, 2024. The number of employees increased by 5 or 2.40% compared to the previous year.
Employees
213
Change (1Y)
5
Growth (1Y)
2.40%
Revenue / Employee
$290,329
Profits / Employee
$25,324
Market Cap
210.70M
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| Humacyte | 220 |
| Voyager Therapeutics | 172 |
| Cibus | 159 |
| MediWound | 111 |
| Alector | 103 |
| Keros Therapeutics | 82 |
| Camp4 Therapeutics | 55 |
| Sol-Gel Technologies | 34 |
PLX News
- 4 weeks ago - A March Decision That Could Change Protalix BioTherapeutics Outlook - Seeking Alpha
- 5 weeks ago - Chiesi Global Rare Diseases and Protalix BioTherapeutics Receive Positive CHMP Opinion for an Additional Dosing Regimen of Every Four Weeks for Elfabrio® (pegunigalsidase alfa) in the EU - GlobeNewsWire
- 5 weeks ago - Chiesi Global Rare Diseases and Protalix BioTherapeutics Receive Positive CHMP Opinion for an Additional Dosing Regimen of 2mg/kg Body Weight Every-Four-Weeks for Elfabrio® (pegunigalsidase alfa) ▼ in the EU - GlobeNewsWire
- 2 months ago - Protalix BioTherapeutics Letter to Stockholders - PRNewsWire
- 2 months ago - Protalix Biotherapeutics and Secarna Pharmaceuticals Enter into Collaboration and Option Agreement - PRNewsWire
- 4 months ago - Protalix BioTherapeutics, Inc. (PLX) Q3 2025 Earnings Call Transcript - Seeking Alpha
- 4 months ago - Protalix BioTherapeutics Reports Third Quarter 2025 Financial and Business Results - PRNewsWire
- 4 months ago - Protalix BioTherapeutics to Announce Third Quarter 2025 Financial and Business Results on November 13, 2025 - PRNewsWire